Skip to content
Subscriber Only

India Has Potential to Increase Covid Testing 10-Fold, Drugmaker Exec Says

  • Founder of drug making firm speaks at Bloomberg India Forum
  • Vaccine logistics a major challenge for India: Mazumdar-Shaw
Video player cover image
WATCH: Kiran Mazumdar-Shaw, chairman of Indian drug-maker Biocon Ltd., says the country has the ability to aggressively ramp up coronavirus testing capacity. (Source: Bloomberg)
Updated on

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

India has the ability to aggressively ramp up coronavirus testing capacity, a move that will help it check a wave of new active cases hitting hospitals and skirt an economically unviable lockdown, according to the head of one of the country’s largest drug makers.